Molecular basis of androgen blockade in prostate cancer.
The molecular basis for antiandrogen therapy is reviewed. This article covers the structure and function of the androgen receptor, including the relationship between mutations in the receptor and the acquisition of androgen independent growth. Implications for anti-androgen therapy are addressed.
Department of Urology, Montreal General Hospital, McGill University, Montreal, Quebec.
Armen G.
AG
Aprikian